Laparoscopic Wilms Tumor Nephrectomy and Lymph Node Sampling: Oncotechnical Considerations Authors: Nitin James Peters, B Sashikiran, Ravi Prakash Kanojia, Muneer Abas Malik, Indu Mohini Sen, Shailesh Solanki, Monika Bawa, Jai Kumar Mahajan, Deepak Bansal Published: 2026 ABSTRACT ABSTRACTWilms tumor (WT) is the most prevalent pediatric renal malignancy, with surgical intervention being a cornerstone of multimodal management. This report evaluates the surgical feasibility, oncotechnical considerations, and short-term outcomes of laparoscopic WT nephrectomy (LWTN) in 17 children following neoadjuvant chemotherapy (NACT). LWTN was successfully completed in 47.1% (8/17) of cases, with conversions primarily necessitated by intraoperative bleeding, efforts to prevent tumor rupture, and strict adherence to oncological principles. The primary advantages observed with LWTN versus laparoscopic converted to open surgery were reduced blood loss (median 20 ml vs. 40 ml, P = 0.014), shorter hospitalization duration (3.13 vs. 4.11 days, P = 0.023), and lower postoperative pain scores (3.50 vs. 5.56, P = 0.001). Lymph node yields (mean: 9.75 vs. 15.44; adequate yield defined as >7 nodes) and tumor rupture rates were similar between groups, supporting the oncological safety of LWTN. Overall, LWTN represents a technically demanding approach that provides perioperative benefits in selected patients without compromising short-term oncological outcomes. INTRODUCTION Wilms tumor (WT) most commonly manifests as a unilateral lesion in 90%–95% of cases, with bilateral or multicentric presentations observed particularly in patients with specific genetic predispositions.[1] Effective management of WT necessitates a multidisciplinary approach, wherein complete surgical excision following established oncological protocols is critical for achieving optimal outcomes.[2] Traditionally, open radical nephroureterectomy with lymph node sampling (LNS) has served as the standard surgical intervention.[3] Although laparoscopic WT nephrectomy (LWTN) offers a minimally invasive alternative, it remains technically challenging and has not yet been broadly incorporated into various pediatric oncology guidelines due to concerns such as potential tumor rupture, insufficient LNS, and suboptimal oncological clearance.[45] The selection criteria for patients eligible for LWTN include demonstrating a positive response to neoadjuvant chemotherapy (NACT), as assessed by interval response. Additional requirements specify that the craniocaudal measurement of the tumor should be ≤9%–10% of the patient’s height, the tumor must remain within the ipsilateral borders of the spinal canal of the vertebral body, and its location should be central, ideally with a rim of normal renal tissue present.[67] The principal aim of LWTN is to enhance short-term postoperative recovery while ensuring oncological outcomes equivalent to those achieved through open surgery.[7] Recent advancements in surgical methodology and data suggest that preoperative chemotherapy, as guided by the SIOP 2001 and Umbrella 2016 protocols, promotes tumor shrinkage and encapsulation, thereby mitigating the risk of intraoperative rupture.[8] These developments have contributed to the growing feasibility of laparoscopic approaches in appropriately selected cases, with strict adherence to oncological standards. Within this framework, we detail the technical aspects and assess the feasibility, safety, and short-term surgical and oncological results of LWTN in a consecutive series of pediatric patients. METHODS Study design and setting This cohort study was carried out between December 2023 and April 2025 after the Institutional Ethics Committee approved (INT/IEC/2025/Spl 1736) and informed consent/assent duly obtained by caregivers and children above the age of 7 years. Participants Patients diagnosed with unilateral WT confirmed by FNAC/trucut biopsy, good NACT response, and tumor not crossing the ipsilateral paravertebral line with no extrarenal invasion or vascular thrombus were included in the study. Patients with bilateral WT or recurrence and those considered for nephron-sparing surgery were excluded from the study. Neoadjuvant chemotherapy SIOP 2001 protocol was followed as per institutional practice (vincristine/actinomycin-D ± doxorubicin; 4–6 cycles). Post-NACT contrast-enhanced computed tomography of the abdomen was done in all children, and the inclusion feasibility was assessed before inclusion. The tumor volume was calculated by the standard formula of length × width × thickness × 0.523 cm3. PROCEDURE Mandatory oncological principles Laparoscopic nephrectomy (LWTN) may be deemed appropriate for WT when specific criteria are satisfied: Surgical excision must rigorously adhere to established oncological principles, including mandatory LNSThe neoplasm should be ideally small, centrally located, and preferably surrounded by an adequate margin of normal renal parenchymaThe resected specimen is to be extracted intact within a retrieval bag via a suitably sized, nonmuscle cutting Pfannenstiel incision, without morcellation. This method is critical to prevent the dissemination of tumor cells and to facilitate accurate pathological staging. Surgical excision must rigorously adhere to established oncological principles, including mandatory LNS Surgical excision must rigorously adhere to established oncological principles, including mandatory LNS The neoplasm should be ideally small, centrally located, and preferably surrounded by an adequate margin of normal renal parenchyma The neoplasm should be ideally small, centrally located, and preferably surrounded by an adequate margin of normal renal parenchyma The resected specimen is to be extracted intact within a retrieval bag via a suitably sized, nonmuscle cutting Pfannenstiel incision, without morcellation. This method is critical to prevent the dissemination of tumor cells and to facilitate accurate pathological staging. The resected specimen is to be extracted intact within a retrieval bag via a suitably sized, nonmuscle cutting Pfannenstiel incision, without morcellation. This method is critical to prevent the dissemination of tumor cells and to facilitate accurate pathological staging. Operative technique General anesthesia is administered, with intraoperative monitoring utilizing a SpO₂ probe or Masimo probe, an arterial line for invasive blood pressure measurement, and maintenance of bispectral index between 40 and 60. Nasogastric decompression and urinary bladder catheterization are performed before the procedure [Video 1]. LWTN is undertaken through a transperitoneal route. The patient is placed in the lateral decubitus position, with a size-appropriate roll under the flank. Approximately 30° of table tilt is given, elevating the affected side. Access is initiated by inserting a 10-mm umbilical port using the open Hasson technique, followed by placement of two to three additional 5-mm working ports as required. Assessment of the tumor’s anatomical location, degree of fixation, and involvement of adjacent structures determines the feasibility of complete resection. The colon is mobilized, and the renal hilum is meticulously dissected to expose the renal artery and vein. For right-sided tumors extending just at or slightly beyond the ipsilateral spinous processes, the Kocher maneuver is employed to mobilize the duodenum and improve hilar access. For left-sided tumors, the lateral peritoneal attachments of the spleen are divided, and the distal pancreas is gently retracted superomedially to enhance visualization of the renal hilum [Figure 1a]. (a) Laying open of renal hilum with cranial pancreatic retraction. Pancreas and retracted ureter marked in yellow, Hilar area marked with yellow circle. (b) Ureteral hitch with Prolene stitch The ureter is elevated upward and slightly caudad from outside the abdominal wall using a Prolene 3-0 hitch suture, thereby optimizing exposure [Figure 1b]. In cases of dense adhesions over major vessels, dissection begins at the iliac vessels – right for the inferior vena cava and left for the aorta – and proceeds cranially toward the renal vessels. Once the renal vein and artery are clearly identified, they are ligated and divided utilizing hem-o-Lok clips (size ML), Liga clips®, or intracorporeal suturing with 3-0 or 2-0 Mer silk® [Figure 2]. Hilar vessels’ identification, ligation, and division The ureter is then ligated and transected as near to the bladder as possible. Preservation of the adrenal gland and gonadal vessels is attempted whenever feasible. Gerota’s fascia and the lateral and superior renal attachments are divided using an appropriate energy device. Traction on the ureter facilitates dissection of the lower pole of the kidney. The tumor specimen is removed within an Endo Catch® bag or equivalent retrieval system through a nonmuscle cutting Pfannenstiel incision [Figure 3a and b]. (a) Specimen retrieved in an Endo catch® bag. (b) Nonmuscle cutting Pfannenstiel incision Lymph node sampling Systematic LNS is a critical aspect of the surgical management of WT. All visibly enlarged lymph nodes within the renal hilum, as well as in the para-aortic and paracaval regions, should be sampled. When managing more “difficult” tumors, it may be preferable to perform LNS before the nephrectomy by applying traction to the ureter, facilitating procedural compliance. If LNS is conducted following nephrectomy, repositioning the camera to the upper port allows for visualization of the retroperitoneal space in a craniocaudal direction, along the great vessels. A minimum of seven visible lymph nodes should be sampled. In situations where lymph nodes are not clearly identifiable, fibrofatty tissue from the standard anatomical locations – the hilum, para-aortic region on the left, and paracaval region on the right – should be excised and submitted for histopathological examination [Figure 4]. Lymph node sampling (marked with green arrow) Extensive lymphadenectomy is not recommended, as it may increase the risk of retroperitoneal complications such as adhesions without conferring additional oncological benefit. RESULTS Of the 94 children diagnosed with WT, an LWTN was attempted in 17 patients (18% of the total cohort). Successful completion of the LWTN occurred in eight patients (47.1%). The mean operative time in the LWTN group was 1.94 ± 0.68 h, compared to 2.33 ± 0.43 h in the group converted from LWTN to open surgery; however, this difference was not statistically significant. All patients in the LWTN group experienced blood loss ≤30 ml (median, 20 ml), while 71.4% of those requiring conversion had blood loss >30 ml, with a median of 40 ml (P = 0.014). Intraoperative bleeding, loss of vision, and inability to proceed after a significant duration of time were the most frequent reasons for conversion, and tumor rupture occurred in two patients – both within the converted group. The Pfannenstiel incision for tumor removal ranged between 4 cm and 7 cm, which correlated with the transverse diameter of the tumor. Postoperative recovery favored the LWTN cohort, with immediate postoperative outcomes and relevant short-term oncological outcomes. The average lymph node yield was 9.75 ± 1.58 in the LWTN group and 15.44 ± 5.98 in the converted group, demonstrating a statistically significant difference (P = 0.020); nevertheless, adequate LNS (≥7 nodes) was achieved in all cases of LWTN. Adjuvant chemotherapy was started sooner in the LWTN group, with a mean interval of 1.63 ± 0.44 weeks, compared to 2.56 ± 0.53 weeks in the converted group (P < 0.001) [Table 1]. Table 1Outcome analysisLWTN GroupLaparoscopic converted to open group P Number of patients (%)8/17 (47.1)9/17 (52.9)0.43Mean operating time (h)1.94±0.682.33±0.430.20Median blood loss (mL)30400.014Postoperative feeding (full feeds)Day 1–2Day 3–40.048Postoperative pain scores Day 03.5±0.755.56±1.014<0.001 Day 30.5±0.531.67±0.700.02Length of hospital stay (days)3.12±0.354.11±0.780.023Oncological parameters LNY*9.75±1.5815.44±5.980.20 Initiation of adjuvant chemotherapy (days)1.625±0.442.556±0.527<0.001*The LNY was less in LWTN when compared to the converted group; however, it remained more than the recommended sampling (highest in the current literature review). LNY: Lymph node yield, LWTN: Laparoscopic Wilms tumor nephrectomy Outcome analysis *The LNY was less in LWTN when compared to the converted group; however, it remained more than the recommended sampling (highest in the current literature review). LNY: Lymph node yield, LWTN: Laparoscopic Wilms tumor nephrectomy DISCUSSION This cohort demonstrates the complexities and limitations associated with minimally invasive surgery in WT, aligning with findings from previous research. Studies have reported an 8% conversion rate among 75 WT patients undergoing LWTN, primarily due to bleeding and inadequate visualization.[910] In contrast, our study observed a higher conversion rate, which may be attributed to factors such as the limited sample size, the initial phase of the learning curve, and stringent intraoperative safety protocols that encourage early conversion to avoid adverse outcomes. In addition, tumor attributes in the Indian Scenario, including larger dimensions, adhesions resulting from pretreatment tumor rupture, and complex hilar anatomy, and completion of adequate LNS contributed to increased conversion rates in this cohort. The authors strictly adhered to the oncological principles, with a low threshold for conversion. Tumor rupture remains a significant intraoperative complication, as it can result in upstaging of the tumor and elevated risk of local recurrence and necessitate more intensive adjuvant therapy. Data from the National WT Study Group, covering over 2000 cases, documented an overall intraoperative tumor rupture rate of 4.6%–11%.[9] More recent investigations focusing on LWTN have identified higher rupture rates (8%–12%) compared to open surgical approaches, likely reflecting technical challenges in tumor handling.[11] In this study, patients who converted from LWTN to open surgery demonstrated a significantly higher mean lymph node yield, although the LWTN group also exceeded the internationally recommended minimum of seven lymph nodes for accurate staging.[12] The increased lymph node retrieval observed in our cohort highlights the benefits of enhanced magnification offered by laparoscopy for retroperitoneal access.[13] This finding contrasts with existing literature, which generally reports lower lymph node yields in laparoscopic procedures. Nonetheless, strict adherence to established oncological principles in this cohort contributed to improved lymph node retrieval outcomes. CONCLUSIONS LWTN has been shown to be both feasible and safe in selected pediatric patients following NACT. It offers superior short-term perioperative outcomes – including decreased intraoperative blood loss, reduced hospital length of stay, lower pain levels, and earlier initiation of adjuvant therapy, when compared to cases converted to open surgery. Short-term oncological parameters, such as R0 resection rates and adequate LNS (≥7 nodes), are comparable between the groups, indicating that LWTN maintains short-term oncologic efficacy without compromising staging accuracy or patient safety. Conflicts of interest There are no conflicts of interest. Video available on: www.jiaps.com